| The Effect of Intravitreal Bevacizumab Injection in Eales' Disease. |
|
Sang Won Moon, Yumi Song, Hee Yoon Cho, Byung Ro Lee, Jun Hong Sohn, Young Sook Park |
1Department of Ophthalmology, College of Medicine, Hanyang University Hospital, Seoul, Korea.
2HanGil Eye Hospital, Incheon, Korea. parkys73@lycos.co.kr |
| 일스병에서 유리체강내 베바시주맙 주입술의 효과 |
|
문상원1ㆍ송유미1ㆍ조희윤1ㆍ이병로1ㆍ손준홍2ㆍ박영숙2 |
|
Department of Ophthalmology, College of Medicine, Hanyang University Hospital1, Seoul, Korea / HanGil Eye Hospital2, Incheon, Korea |
|
|
| Abstract |
PURPOSE
To report on 2 cases of Eales' disease that were successfully regressed with laser photocoagulation and intravitreal bevacizumab (Avastin; Genetech, Inc, San Francisco, California, USA) injection. CASE SUMMARY: Two male patients (30 years and, 40 years of age,) with a history of recurrent vitreous hemorrhage were diagnosed with Eales' disease. The 2 patients had peripheral retina neovascularization and active phlebitis in fundus fluorescein angiography. No other findings were observed in their eyes in the general examination. Scatter laser photocoagulation and intravitreal bevacizumab injection were performed. After 1 month follow-up, neovascularization completely regressed. There was no complication or recurrent vitreous hemorrhage at the 1 year follow up. CONCLUSIONS: Intravitreal bevacizumab injection, as combination treatment of laser photocoagulation, may be helpful in the regression of neovascularization due to Eales' disease. |
| Key Words:
Eales' disease;Intravitreal bevacizumab injection;Laser photocoagulation |
|
PDF Links
Full text via DOI
Download Citation
